Israel’s BioGenCell (see here previously) has completed Phase 1 clinical trials at Israel’s Laniado Medical Center, of its stem cell therapy to cure chronic limb-threatening ischemia (CLI). Nine patients have had their legs saved from amputation. BioGenCell will now proceed to Phase 2 trials.
Curing blood flow blockages
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.